Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients
Article in Communications Medicine (October 2023)
The most recent citing publications are shown below. View all 127 publications that cite this research output on Dimensions.
Article in Communications Medicine (October 2023)
Article in European Journal of Pharmaceutics and Biopharmaceutics (September 2023)
Article in Frontiers in Oncology (July 2023)